홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

N,N-Dimethylsulfamide → 7H-indolo[2,1-a][2]benzazepine-10-carboxamide

HRID 1453356
인쇄

반응식

HRID 1453356 반응식
[CH:1]1[C:11]2[C:10]3=[CH:12][C:13]4[CH:14]=[CH:15][C:16]([C:19]([O:21]C)=O)=[CH:17][C:18]=4[N:9]3[CH2:8][CH:7]=[CH:6][C:5]=2[CH:4]=[CH:3][CH:2]=1.Cl.C1C2C3C(C(=O)N2CC[NH:25]1)=CC=CC=3.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CN(C)S(N)(=O)=O.Cl.CN(C)CCCN=C=NCC>CN(C=O)C.O.CN(C1C=CN=CC=1)C.CC(N(C)C)=O.C(N(CC)CC)C>[CH:1]1[C:11]2[C:10]3=[CH:12][C:13]4[CH:14]=[CH:15][C:16]([C:19]([NH2:25])=[O:21])=[CH:17][C:18]=4[N:9]3[CH2:8][CH:7]=[CH:6][C:5]=2[CH:4]=[CH:3][CH:2]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

11

반응물 5

HCID 134472N,N-DimethylsulfamideHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 129017791,2,3,4-Tetrahydropyrazino[2,1-a]isoindol-6(10bh)-one hydrochlorideHCID 68832135methyl 7H-indolo[2,1-a][2]benzazepine-10-carboxylate

생성물 1

HCID 666396907H-indolo[2,1-a][2]benzazepine-10-carboxamide

시약·촉매·용매 5

HCID 142844-(Dimethylamino)pyridine촉매HCID 962Water용매2회HCID 6228Dimethylformamide용매HCID 8471Triethylamine용매HCID 31374Dimethylacetamide용매

실험 절차

To a stirred solution of methyl 7H-indolo[2,1-a][2]benzazepine-10-carboxylate, 13-cyclohexyl, 6-carboxylic acid (200 mg, 0.48 mmol), 1,2,3,4-tetrahydropyrazino[2,1-a]isoindol-6(10bH)-one hydrochloride (130 mg, 0.58 mmol) and triethylamine (0.20 mL) in DMF (3 mL) was added HATU (220 mg, 0.58 mmol). The reaction mixture was stirred at rt for 1 h, diluted with H2O (˜5 mL) stirred for 30 min, and the solids (288 mg) collected by filtration and flushed with H2O. The crude solids were dissolved into MeOH/THF (1:1, 4 mL) and treated with 1M aqueous NaOH (0.75 mL). The reaction mixture was stirred and heated at 80° C. with microwave irradiation for 15 min in a sealed tube. The clear solution was diluted with H2O (5 mL), neutralized with 1M aqueous HCl (0.75 mL) and concentrated to remove organic solvents. The resultant solids (247 mg) were collected by filtration and washed with H2O. To a stirred solution of the crude solids (150 mg, 61% of total collected, ˜0.25 mmol), N,N-dimethylsulfamide (155 mg, 1.25 mmol) and DMAP (150 mg, 1.25 mmol) in dimethylacetamide (2 mL) was added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (190 mg, 1.0 mmol). The reaction solution was stirred at 50° C. for 2h, diluted with water (5 mL) and the resulting solids were collected by filtration. The mother liquor was concentrated and the solids and the mother liquor were independently purified by preparative HPLC (MeOH/2O with NH4OAc buffer) to yield 7H-indolo[2,1-a][2]benzazepine-10-carboxamide, 13-cyclohexyl-N-[(dimethylamino)sulfonyl]-6-[(3,4,6,10b-tetrahydro-6-oxopyrazino[2,1-a]isoindol-2(1H)-yl)carbonyl] (71 mg total, 27 mg from solids and 44 mg from mother liquor, 0.09 mol, 36% over 3 steps) as a yellow solid. 1H NMR (500 MHz, CDCl3) δ 8.96 (br s, 1H), 8.15 (s, 1H), 7.94 (d, J=8.6 Hz, 1H), 7.83 (s, 1H), 7.62 (d, J=7.6 Hz, 1H), 7.57-7.38 (m, 7H), 6.96 (s, 1H), 5.20 (br s, 1H), 4.44 (br s, 1H), 4.38-3.70 (m, 3H), 3.23-2.66 (m, 5H), 2.98 (s, 6H), 2.11-1.17 (m, 10H). LCMS: m/e 676 (M−H)−, ret time 1.61 min, column A, 2 minute gradient.

후처리

  1. stirringstirred for 30 min
  2. filtrationthe solids (288 mg) collected by filtration
  3. customflushed with H2O
  4. dissolutionThe crude solids were dissolved into MeOH/THF (1:1, 4 mL)
  5. additiontreated with 1M aqueous NaOH (0.75 mL)
  6. stirringThe reaction mixture was stirred
  7. temperatureheated at 80° C. with microwave irradiation for 15 min in a sealed tube
  8. additionThe clear solution was diluted with H2O (5 mL)
  9. concentrationconcentrated
  10. customto remove organic solvents
  11. filtrationThe resultant solids (247 mg) were collected by filtration
  12. washwashed with H2O
  13. filtrationthe resulting solids were collected by filtration
  14. concentrationThe mother liquor was concentrated
  15. customthe solids and the mother liquor were independently purified by preparative HPLC (MeOH/2O with NH4OAc buffer)

출처 및 근거

ORD 기록
ord-0d612cbb58ab4befa3e2bb733ec6f512
출처 데이터셋
uspto-grants-2009_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07473688B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트